
Organigram takes stake in German cannabis firm Sanity Group with $21M investment
BNN Bloomberg
Organigram Holdings Inc. says it has taken a minority stake in European cannabis company Sanity Group through a $21 million investment.
Moncton-based pot producer Organigram says it may eventually advance another $4.5 million to Sanity through an unsecured convertible note, which made up the bulk of its initial investment.
The investment is meant to help Organigram capitalize on the recent legalization of cannabis in Germany, where Sanity is based and holds a roughly 10 per cent share of the medical pot market.
The arrangement could also see the companies deepen their presence in Switzerland, where Sanity is involved in a recreational pot pilot and is expected to invest in distribution channels.

U.S. President Donald Trump on Monday said the U.S. was talking with a “respected” Iranian leader and claimed the Islamic Republic was eager for a deal to end the war. He also extended a deadline for Iran to reopen the crucial Strait of Hormuz or face attacks on its power plants, saying it has an additional five days.

Jurors wade through daunting evidence in high-stakes Meta trial about social media risks to children
A stream of testimony and evidence has been presented in a New Mexico case exploring what Meta knew about the effects of its platforms on children.











